Instil Bio
64 hedge funds and large institutions have $1.28B invested in Instil Bio in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 7 closing their positions.
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
13% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 16
3% more funds holding
Funds holding: 62 → 64 (+2)
0.06% more ownership
Funds ownership: 2.74% → 2.79% (+0.06%)
5% less capital invested
Capital invested by funds: $1.35B → $1.28B (-$61.6M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.7M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$2.38M |
| 3 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
+$1.83M |
| 4 |
E
Ergoteles
New York
|
+$1.49M |
| 5 |
PM
Parametrica Management
Wanchai,
Hong Kong
|
+$863K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$7.83M |
| 2 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$3.24M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.08M |
| 4 |
Morgan Stanley
New York
|
-$930K |
| 5 |
D.E. Shaw & Co
New York
|
-$820K |
TIL Hedge Fund Activity: Q3 2021 in Review
64 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q3 2021, worth a combined $1.28B — down 4.6% from $1.35B a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new TIL positions and 7 closed out — a net gain of 2 holders — while 18 added to existing stakes and 16 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $31.7M. The largest seller was Logos Global Management, cutting an estimated $7.83M.
- 64 institutional investors held Instil Bio (TIL) as of Q3 2021, up from 62 in Q2 2021.
- Funds reported $1.28B of Instil Bio stock for Q3 2021, down 4.6% quarter-over-quarter.
- 9 funds opened new Instil Bio positions in Q3 2021 and 7 closed out, a net change of +2 holders.
- The largest Instil Bio buyer in Q3 2021 was Fidelity Investments, an estimated $31.7M added.
- The largest Instil Bio seller in Q3 2021 was Logos Global Management, an estimated $7.83M sold.
Based on aggregated 13F filings for Q3 2021.